Panel Discussion: Exploring the Bestin- Class Adjuvant to Improve Patient Response to Neoantigen Therapy
- Discussing the best approach to turn the ‘cold tumor’ into a ‘hot tumor’.
- Outlining the variety of neoadjuvant methods to prime immune responses to neoantigen vaccination
- Exploring the potential of a mRNA adjuvant if an mRNA vaccine platform is used for neoantigen delivery